Compare FNLC & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNLC | TOI |
|---|---|---|
| Founded | 1864 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 306.9M | 327.6M |
| IPO Year | 1995 | N/A |
| Metric | FNLC | TOI |
|---|---|---|
| Price | $27.96 | $3.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.67 |
| AVG Volume (30 Days) | 14.0K | ★ 2.3M |
| Earning Date | 04-22-2026 | 03-12-2026 |
| Dividend Yield | ★ 5.25% | N/A |
| EPS Growth | ★ 26.34 | N/A |
| EPS | ★ 3.07 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.15 |
| Revenue Next Year | N/A | $25.77 |
| P/E Ratio | $9.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.11 | $1.03 |
| 52 Week High | $30.33 | $4.88 |
| Indicator | FNLC | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | 50.99 |
| Support Level | $25.98 | $2.98 |
| Resistance Level | $28.55 | $3.74 |
| Average True Range (ATR) | 0.64 | 0.34 |
| MACD | 0.08 | -0.03 |
| Stochastic Oscillator | 61.67 | 37.82 |
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.